Abatacept
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5250 publications
Immune Checkpoint Inhibitor Myocarditis and Myotoxicity.
Journal: Circulation
Published: September 08, 2026
IgG4-related disease - treatment with anti-CD20, anti-CD19 antibodies, and other new drugs.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: August 28, 2026
Cancer Risk in Kidney Transplant Recipients on Belatacept Versus Calcineurin Inhibitors: A Systematic Review and Meta-Analysis.
Journal: Transplantation
Published: August 27, 2026
Persistent Cytotoxic Immune Signaling in Anti-VEGF-Treated Neovascular Age-Related Macular Degeneration.
Journal: medRxiv : the preprint server for health sciences
Published: August 26, 2026
Contemporary Guideline Perspectives on Methotrexate and Biologic/Targeted Synthetic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Journal: Internal medicine (Tokyo, Japan)
Published: August 26, 2026
Assessing the real-world impact of interstitial lung disease in patients with rheumatoid arthritis on healthcare resources and treatment patterns through natural language processing.
Journal: EULAR rheumatology open
Published: August 01, 2026
Effect of Immunosuppressive Drugs on Glucose-Stimulated Insulin Secretion: Concentration-Response Studies in Dynamic Perifusion Assays.
Journal: bioRxiv : the preprint server for biology
Published: July 29, 2026
Characterization of abatacept mediated immunogenicity using domain-specific and neutralizing antibody assays: a biosimilar perspective.
Journal: Bioanalysis
Published: July 27, 2026
Common Immunosuppressants Impair Recipient Immunity but Do Not Safeguard Donor Tissue-resident Immunity in Kidney Transplantation.
Journal: Transplantation
Published: July 20, 2026
Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta-analysis.
Journal: The Cochrane database of systematic reviews
Published: July 13, 2026
Clinical Relevant Immunosuppressive Drugs Differentially Modulate Axonal Outgrowth from Human Stem Cell-Derived Neurons.
Journal: bioRxiv : the preprint server for biology
Published: July 11, 2026
Clinical Relevant Immunosuppressive Drugs Differentially Modulate Axonal Outgrowth from Human Stem Cell-Derived Neurons.
Journal: bioRxiv : the preprint server for biology
Published: July 11, 2026
Last Updated: 09/26/2026